IOVANCE
DEAD

Serial Number

90398614

Owner

IOVANCE BIOTHERAPEUTICS, INC.

Attorney

Carla B. Oakley

Filing Date

Dec 21, 2020

Add to watchlist:

No watchlists yet
View on USPTO

IOVANCE Trademark

Serial Number: 90398614

IOVANCE is a trademark filed by IOVANCE BIOTHERAPEUTICS, INC. on December 21, 2020. The trademark is classified under Class 38 (Telecommunications), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

IOVANCE BIOTHERAPEUTICS, INC. (47 trademarks)

999 SKYWAY ROAD SUITE 150
SAN CARLOS, CA 94070

Entity Type: 03

Trademark Details

Filing Date

December 21, 2020

Registration Date

Not Registered

Published for Opposition

July 20, 2021

Goods & Services

telecommunications services, namely, transmission of voice, audio, data, graphics, and video between patients and healthcare providers via global and local computer networks in the fields of telehealth, telemedicine, remote care, and virtual health care services; providing users with real-time and on-demand access to health care professionals via computer, telephone, and other electronic means via telecommunication networks

providing temporary use of non-downloadable computer software for scheduling and tracking medical patient appointments, medical laboratory services, medical procedures, and for matching patients and medical treatment sites, and for use in providing data analytics in the fields of medical research, cancer treatments and drug and immunotherapy development; providing an interactive website featuring technology that allows users to communicate with patients and manage patient treatment data, for facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, healthcare, telehealth, telemedicine, remote care and virtual health care services; software as a service (SaaS) services featuring software for delivering streamlined medical treatment information and improving communication among stakeholders in medical treatment and medical research; software as a service (SaaS) services featuring software for tracking and monitoring chain of custody and chain of identity of cell therapies; providing medical and scientific research information in the field of drug development and medical treatment development for delivering streamlined treatment information and improving communication among stakeholders in providing medical treatment; providing medical and scientific research information in the fields of medical research and cancer treatments; providing temporary use of non-downloadable software for providing medical referrals; software as a service (SAAS) services featuring software for collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, healthcare, telehealth, telemedicine, remote care, and virtual health care services; software as a service (SAAS) services featuring software for scheduling medical and healthcare services; software as a service (SAAS) services featuring software for providing consultation, and medical care services and information; providing temporary use of on-line non-downloadable software for remote medical consultation in the field of telemedicine; platform as a service (PAAS) featuring computer software platforms for online collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing advice and referrals in the medical and healthcare fields; software as a service (SAAS) services featuring software for managing the supply of tumor shippers, temperature monitors and GPS trackers provided to sites involved in the provision of immunotherapy treatments and cancer treatments

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 21, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 21, 2024 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 14, 2024 EXRA
SOU EXTENSION 5 GRANTED
Mar 13, 2024 EX5G
SOU EXTENSION 5 FILED
Mar 13, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 13, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 16, 2023 EXRA
SOU EXTENSION 4 GRANTED
Aug 14, 2023 EX4G
SOU EXTENSION 4 FILED
Aug 14, 2023 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 14, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 21, 2023 EXRA
SOU EXTENSION 3 GRANTED
Feb 17, 2023 EX3G
SOU EXTENSION 3 FILED
Feb 17, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 3, 2022 EXRA
SOU EXTENSION 2 GRANTED
Sep 1, 2022 EX2G
SOU EXTENSION 2 FILED
Sep 1, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 1, 2022 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 23, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 23, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 23, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 23, 2022 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 27, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 27, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 27, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 14, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 20, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 20, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 30, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 16, 2021 CNSA
ASSIGNED TO EXAMINER
Jun 16, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 5, 2021 NWOS
NEW APPLICATION ENTERED
Dec 24, 2020 NWAP